Back
OncoCyte Stock Price Chart
Sponsored
OCX
Sponsored
U.S. Government Report Alert Tuesday
Discover the Secret Loophole
Sell
43
OCX
OncoCyte
Last Price:
2.79
Seasonality Move:
66.51%
7 Day Trial
ALL ACCESS PASS
$
7
Write This Down: Tuesday at 2 p.m. ET!
Don't Miss Our LIVE Trade- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and OCX is experiencing slight buying pressure.
OncoCyte Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.01 | Sell |
20-day SMA: | 3.06 | Sell |
50-day SMA: | 3.06 | Sell |
200-day SMA: | 2.96 | Sell |
8-day EMA: | 2.99 | Sell |
20-day EMA: | 3.03 | Sell |
50-day EMA: | 3.04 | Sell |
200-day EMA: | 3.26 | Sell |
OncoCyte Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.02 | Sell |
Relative Strength Index (14 RSI): | 40.64 | Sell |
Chaikin Money Flow: | 5897 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.97 - 3.11) | Sell |
Bollinger Bands (100): | (2.9 - 3.2) | Sell |
OncoCyte Technical Analysis
Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for OncoCyte Stock
Is OncoCyte Stock a Buy?
- OncoCyte share price is 2.92 while OCX 8-day simple moving average is 3.01, which is a Sell signal.
- The stock price of OCX is 2.92 while OncoCyte 20-day SMA is 3.06, which makes it a Sell.
- OncoCyte 50-day simple moving average is 3.06 while OCX share price is 2.92, making it a Sell technically.
- OCX stock price is 2.92 and OncoCyte 200-day simple moving average is 2.96, creating a Sell signal.
OCX Technical Analysis vs Fundamental Analysis
OncoCyte Stock Info
Market Cap:
49.16M
Price in USD:
2.92
Share Volume:
21.62K
OncoCyte 52-Week Range
52-Week High:
4.34
52-Week Low:
2.08
Sell
43
OncoCyte (OCX)
is a Sell
OncoCyte Share Price Forecast
-
What is the OncoCyte stock price today?
The OncoCyte stock price is 2.92 USD today. -
Will OCX stock go up or go down?
OncoCyte> share price is forecast to RISE/FALL based on technical indicators -
Is OncoCyte overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, OncoCyte is overvalued.
Is OncoCyte Stock a Buy?
- OncoCyte share price is 2.92 while OCX 8-day exponential moving average is 2.99, which is a Sell signal.
- The stock price of OCX is 2.92 while OncoCyte 20-day EMA is 3.03, which makes it a Sell.
- OncoCyte 50-day exponential moving average is 3.04 while OCX share price is 2.92, making it a Sell technically.
- OCX stock price is 2.92 and OncoCyte 200-day simple moving average is 3.26, creating a Sell signal.
Fundamental Analysis of OncoCyte
Is OncoCyte a good investment?
- Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.17 per share, and an increase next year of $0.68 per share.
Technical Analysis of OncoCyte
Should I short OncoCyte stock?
- OCX Moving Average Covergence Divergence (MACD) indicator is -0.02, suggesting OncoCyte is a Sell
- OncoCyte Relative Strength Index (RSI) is 40.64, which suggest OncoCyte is oversold
- The Bollinger Bands (25) for OncoCyte is (2.97 - 3.11), which suggest OncoCyte is a Sell
- The Bollinger Bands (100) for OncoCyte is (2.9 - 3.2), which suggest OncoCyte is a Sell
* OncoCyte stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.